MENU
+Compare
DSKYF
Stock ticker: OTC
AS OF
Nov 25 closing price
Price
$23.91
Change
+$0.66 (+2.84%)
Capitalization
45.19B

DSKYF stock forecast, quote, news & analysis

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005... Show more

DSKYF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for DSKYF with price predictions
Nov 25, 2025

DSKYF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for DSKYF turned positive on November 20, 2025. Looking at past instances where DSKYF's MACD turned positive, the stock continued to rise in of 63 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on DSKYF as a result. In of 133 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DSKYF advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where DSKYF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

DSKYF moved below its 50-day moving average on November 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DSKYF crossed bearishly below the 50-day moving average on November 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DSKYF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DSKYF broke above its upper Bollinger Band on November 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DSKYF entered a downward trend on November 19, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.203) is normal, around the industry mean (9.013). P/E Ratio (25.086) is within average values for comparable stocks, (24.322). DSKYF's Projected Growth (PEG Ratio) (5.070) is slightly higher than the industry average of (2.089). Dividend Yield (0.020) settles around the average of (0.026) among similar stocks. P/S Ratio (3.546) is also within normal values, averaging (3.702).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DSKYF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DSKYF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

A.I.Advisor
published Dividends

DSKYF paid dividends on June 19, 2018

Daiichi Sankyo Co., Ltd. DSKYF Stock Dividends
А dividend of $35.00 per share was paid with a record date of June 19, 2018, and an ex-dividend date of March 28, 2018. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 101.32B. The market cap for tickers in the group ranges from 72.83K to 993.42B. LLY holds the highest valuation in this group at 993.42B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 2%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 17%. SCLX experienced the highest price growth at 24%, while MAYNF experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 62% and the average quarterly volume growth was 57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 32
P/E Growth Rating: 60
Price Growth Rating: 49
SMR Rating: 63
Profit Risk Rating: 72
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
DSKYF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
3-5-1, Nihonbashi-honcho
Phone
+81 362251111
Employees
14887
Web
https://www.daiichisankyo.com